| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 7.85e-06 | 145 | 99 | 7 | GO:0004713 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 4.14e-05 | 14 | 99 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | NACHT domain binding | 7.28e-05 | 3 | 99 | 2 | GO:0032089 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 9.14e-05 | 18 | 99 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor binding | 1.45e-04 | 4 | 99 | 2 | GO:0031841 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.95e-04 | 23 | 99 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.45e-04 | 441 | 99 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.54e-04 | 28 | 99 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | filamin binding | 3.93e-04 | 29 | 99 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 3.93e-04 | 29 | 99 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 4.76e-04 | 73 | 99 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 6.33e-04 | 34 | 99 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.13e-04 | 37 | 99 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 AK9 SMARCAD1 UPF1 CLPX IQCA1L ACSBG1 ABCD1 DNAH6 DNAH11 | 9.38e-04 | 614 | 99 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | calmodulin binding | 1.01e-03 | 230 | 99 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.05e-03 | 90 | 99 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | delta-catenin binding | 1.30e-03 | 11 | 99 | 2 | GO:0070097 | |
| GeneOntologyMolecularFunction | gamma-catenin binding | 1.55e-03 | 12 | 99 | 2 | GO:0045295 | |
| GeneOntologyMolecularFunction | interleukin-1 binding | 1.55e-03 | 12 | 99 | 2 | GO:0019966 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.55e-03 | 12 | 99 | 2 | GO:0017154 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.85e-03 | 49 | 99 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | alpha-mannosidase activity | 2.45e-03 | 15 | 99 | 2 | GO:0004559 | |
| GeneOntologyBiologicalProcess | negative regulation of protein kinase activity | 1.05e-05 | 221 | 98 | 8 | GO:0006469 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | ABL1 ABL2 PSG2 PSG11 APC S1PR1 PTPRT RYK MAGI2 SRPX2 SEMA6D TJP1 FGF3 DAAM2 PSG8 MED23 PLXNB1 PLXNB3 SCAI | 1.33e-05 | 1327 | 98 | 19 | GO:0040012 |
| GeneOntologyBiologicalProcess | cell junction organization | ABL1 ABL2 PSG2 PSG11 APC SPG11 ARHGAP39 PTPRT RYK MAGI2 SLC8A3 SRPX2 UBE3A TJP1 PSG8 PLXNB1 | 1.34e-05 | 974 | 98 | 16 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of cell migration | ABL1 ABL2 PSG2 PSG11 APC S1PR1 PTPRT MAGI2 SRPX2 SEMA6D TJP1 FGF3 DAAM2 PSG8 MED23 PLXNB1 PLXNB3 SCAI | 1.41e-05 | 1211 | 98 | 18 | GO:0030334 |
| GeneOntologyBiologicalProcess | negative regulation of kinase activity | 1.69e-05 | 236 | 98 | 8 | GO:0033673 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 2.54e-05 | 73 | 98 | 5 | GO:0042304 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | ABL1 ABL2 PSG2 PSG11 APC S1PR1 PTPRT MAGI2 SRPX2 SEMA6D TJP1 FGF3 DAAM2 PSG8 MED23 PLXNB1 PLXNB3 SCAI | 2.96e-05 | 1280 | 98 | 18 | GO:2000145 |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 3.29e-05 | 77 | 98 | 5 | GO:0035567 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 3.64e-05 | 14 | 98 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | 4.12e-05 | 434 | 98 | 10 | GO:0062012 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 4.54e-05 | 15 | 98 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 4.54e-05 | 15 | 98 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 4.54e-05 | 15 | 98 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 4.54e-05 | 15 | 98 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | negative regulation of transferase activity | 4.78e-05 | 273 | 98 | 8 | GO:0051348 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 5.57e-05 | 16 | 98 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 6.74e-05 | 17 | 98 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 6.74e-05 | 17 | 98 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 6.74e-05 | 17 | 98 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | 7.47e-05 | 375 | 98 | 9 | GO:0001933 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 8.06e-05 | 18 | 98 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | sprouting angiogenesis | 8.68e-05 | 220 | 98 | 7 | GO:0002040 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | RANBP2 ABL1 PSG2 PSG11 ROR1 APC PTPRT RYK SLC8A3 PTPRB PSG8 SNX9 | 9.90e-05 | 686 | 98 | 12 | GO:0043549 |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.12e-04 | 20 | 98 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorylation | 1.24e-04 | 401 | 98 | 9 | GO:0042326 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.30e-04 | 21 | 98 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.30e-04 | 21 | 98 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.30e-04 | 21 | 98 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | DN4 thymocyte differentiation | 1.33e-04 | 4 | 98 | 2 | GO:1904157 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of T cell polarity | 1.33e-04 | 4 | 98 | 2 | GO:1903905 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 1.36e-04 | 55 | 98 | 4 | GO:0060071 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.50e-04 | 22 | 98 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | ABL1 ABL2 ROR1 PLA2G3 RYK XYLT1 MAGI2 SEMA6D UBE3A PLXNB1 PLXNB3 | 1.55e-04 | 612 | 98 | 11 | GO:0010975 |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.72e-04 | 23 | 98 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.72e-04 | 23 | 98 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ABL1 ABL2 ROR1 PLA2G3 APC RYK XYLT1 MAGI2 SEMA6D UBE3A DAAM2 PLXNB1 PLXNB3 | 1.82e-04 | 846 | 98 | 13 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1.93e-04 | 334 | 98 | 8 | GO:0051896 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.96e-04 | 24 | 98 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.96e-04 | 24 | 98 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.96e-04 | 24 | 98 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 2.03e-04 | 61 | 98 | 4 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ABL1 ABL2 ROR1 PLA2G3 APC RYK XYLT1 MAGI2 SEMA6D UBE3A DAAM2 PLXNB1 PLXNB3 | 2.21e-04 | 863 | 98 | 13 | GO:0031344 |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 2.22e-04 | 25 | 98 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 2.22e-04 | 25 | 98 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 2.80e-04 | 27 | 98 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 2.86e-04 | 189 | 98 | 6 | GO:0010565 | |
| GeneOntologyBiologicalProcess | behavior | ABL1 ABL2 PSG2 PSG11 PYY SPG11 SLC8A3 SRPX2 CLCN3 UBE3A PSG8 NPY DNAH11 | 3.00e-04 | 891 | 98 | 13 | GO:0007610 |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 3.03e-04 | 191 | 98 | 6 | GO:0006633 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 3.13e-04 | 28 | 98 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of establishment of T cell polarity | 3.31e-04 | 6 | 98 | 2 | GO:1903903 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 3.46e-04 | 70 | 98 | 4 | GO:0045124 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 3.47e-04 | 29 | 98 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | RANBP2 NIBAN1 ABL1 PSG2 PSG11 ROR1 APC BEND3 PTPRT RYK MAGI2 SLC8A3 SRPX2 PTPRB FGF3 PSG8 SNX9 | 3.56e-04 | 1421 | 98 | 17 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | RANBP2 NIBAN1 ABL1 PSG2 PSG11 ROR1 APC BEND3 PTPRT RYK MAGI2 SLC8A3 SRPX2 PTPRB FGF3 PSG8 SNX9 | 3.62e-04 | 1423 | 98 | 17 | GO:0051174 |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 3.65e-04 | 71 | 98 | 4 | GO:0043114 | |
| GeneOntologyBiologicalProcess | synapse organization | ABL1 ABL2 SPG11 ARHGAP39 PTPRT RYK MAGI2 SLC8A3 SRPX2 UBE3A PLXNB1 | 4.07e-04 | 685 | 98 | 11 | GO:0050808 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 4.24e-04 | 31 | 98 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 4.50e-04 | 134 | 98 | 5 | GO:0019217 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphate metabolic process | 4.54e-04 | 478 | 98 | 9 | GO:0045936 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | RANBP2 ABL1 PSG2 PSG11 ROR1 APC PTPRT RYK SLC8A3 PTPRB PSG8 SNX9 | 4.55e-04 | 810 | 98 | 12 | GO:0051338 |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 4.67e-04 | 32 | 98 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 4.67e-04 | 32 | 98 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of non-canonical Wnt signaling pathway | 4.67e-04 | 32 | 98 | 3 | GO:2000050 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 4.67e-04 | 32 | 98 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorus metabolic process | 4.68e-04 | 480 | 98 | 9 | GO:0010563 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 4.75e-04 | 382 | 98 | 8 | GO:0043491 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 5.12e-04 | 33 | 98 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 5.12e-04 | 33 | 98 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 5.31e-04 | 139 | 98 | 5 | GO:0007173 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 5.59e-04 | 34 | 98 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 5.59e-04 | 34 | 98 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 5.75e-04 | 80 | 98 | 4 | GO:0046850 | |
| GeneOntologyBiologicalProcess | T cell migration | 6.02e-04 | 81 | 98 | 4 | GO:0072678 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 6.10e-04 | 35 | 98 | 3 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | RANBP2 NIBAN1 ABL1 PSG2 PSG11 ROR1 APC PTPRT RYK SLC8A3 SRPX2 PTPRB FGF3 PSG8 SNX9 | 6.53e-04 | 1226 | 98 | 15 | GO:0042325 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 6.61e-04 | 83 | 98 | 4 | GO:0002707 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 6.96e-04 | 405 | 98 | 8 | GO:0033674 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 7.23e-04 | 85 | 98 | 4 | GO:1903670 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification process | 7.42e-04 | 512 | 98 | 9 | GO:0031400 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 7.78e-04 | 38 | 98 | 3 | GO:2000345 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 7.84e-04 | 516 | 98 | 9 | GO:0016055 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 8.35e-04 | 747 | 98 | 11 | GO:0007169 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 8.40e-04 | 39 | 98 | 3 | GO:0045717 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | ABL1 ABL2 PSG2 PSG11 PYY APC S1PR1 TRIM16 MAGI2 TJP1 PSG8 NPY | 8.53e-04 | 870 | 98 | 12 | GO:0030855 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 9.05e-04 | 40 | 98 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | RANBP2 NIBAN1 ABL1 PSG2 PSG11 ROR1 BEND3 RYK MAGI2 FGF3 PSG8 SNX9 | 9.32e-04 | 879 | 98 | 12 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | RANBP2 NIBAN1 ABL1 PSG2 PSG11 ROR1 BEND3 RYK MAGI2 FGF3 PSG8 SNX9 | 9.32e-04 | 879 | 98 | 12 | GO:0010562 |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 9.48e-04 | 158 | 98 | 5 | GO:0045446 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 9.73e-04 | 41 | 98 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 9.73e-04 | 41 | 98 | 3 | GO:2000406 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 9.81e-04 | 10 | 98 | 2 | GO:1990264 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway, planar cell polarity pathway | 9.81e-04 | 10 | 98 | 2 | GO:2000096 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 1.00e-03 | 160 | 98 | 5 | GO:0038127 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.04e-03 | 42 | 98 | 3 | GO:0090330 | |
| GeneOntologyBiologicalProcess | feeding behavior | 1.06e-03 | 162 | 98 | 5 | GO:0007631 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.14e-03 | 96 | 98 | 4 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of lipid biosynthetic process | 1.14e-03 | 246 | 98 | 6 | GO:0046890 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | RANBP2 ABL1 ABL2 PSG2 PSG11 ROR1 RYK MAGI2 TBC1D4 PSG8 DOCK6 SNX9 PLXNB1 | 1.14e-03 | 1028 | 98 | 13 | GO:0043085 |
| GeneOntologyBiologicalProcess | positive regulation of unsaturated fatty acid biosynthetic process | 1.20e-03 | 11 | 98 | 2 | GO:2001280 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 1.22e-03 | 249 | 98 | 6 | GO:0010976 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 5.52e-05 | 16 | 99 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 6.88e-05 | 90 | 99 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | cell surface | PSG2 PSG7 PSG11 ROR1 PKD1L3 CR2 S1PR1 PTPRT SRPX2 CLCN3 SEMA6D TJP1 SLC39A6 PSG8 PLXNB3 | 2.25e-04 | 1111 | 99 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | receptor complex | 4.32e-04 | 581 | 99 | 10 | GO:0043235 | |
| GeneOntologyCellularComponent | neuron projection terminus | 8.50e-04 | 233 | 99 | 6 | GO:0044306 | |
| GeneOntologyCellularComponent | presynapse | HCN4 WDR7 ROR1 APC S1PR1 RYK MYOF SLC8A3 CLCN3 UBE3A SNX9 NPY | 9.74e-04 | 886 | 99 | 12 | GO:0098793 |
| GeneOntologyCellularComponent | inner dynein arm | 9.75e-04 | 10 | 99 | 2 | GO:0036156 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 4.55e-05 | 35 | 80 | 4 | MP:0031618 | |
| MousePheno | decreased muscle cell glucose uptake | 7.02e-05 | 39 | 80 | 4 | MP:0030022 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 1.13e-04 | 44 | 80 | 4 | MP:0031023 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.16e-04 | 17 | 80 | 3 | MP:0031047 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.47e-04 | 47 | 80 | 4 | MP:0031617 | |
| MousePheno | increased incidence of tumors by chemical induction | 1.54e-04 | 141 | 80 | 6 | MP:0004499 | |
| Domain | FABD | 2.78e-05 | 2 | 99 | 2 | SM00808 | |
| Domain | F_actin_bind | 2.78e-05 | 2 | 99 | 2 | PF08919 | |
| Domain | F-actin_binding | 2.78e-05 | 2 | 99 | 2 | IPR015015 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.04e-05 | 14 | 99 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.04e-05 | 14 | 99 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.04e-05 | 14 | 99 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.04e-05 | 14 | 99 | 3 | PF08393 | |
| Domain | MT | 5.04e-05 | 14 | 99 | 3 | PF12777 | |
| Domain | AAA_8 | 5.04e-05 | 14 | 99 | 3 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 5.04e-05 | 14 | 99 | 3 | IPR011704 | |
| Domain | AAA_5 | 5.04e-05 | 14 | 99 | 3 | PF07728 | |
| Domain | DHC_fam | 6.28e-05 | 15 | 99 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 6.28e-05 | 15 | 99 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 6.28e-05 | 15 | 99 | 3 | PF03028 | |
| Domain | Pancreatic_hormone-like | 8.32e-05 | 3 | 99 | 2 | PD001267 | |
| Domain | PAH | 8.32e-05 | 3 | 99 | 2 | SM00309 | |
| Domain | Pancreatic_hormone-like_CS | 8.32e-05 | 3 | 99 | 2 | IPR020392 | |
| Domain | Pancreatic_hormone-like | 8.32e-05 | 3 | 99 | 2 | IPR001955 | |
| Domain | PANCREATIC_HORMONE_2 | 8.32e-05 | 3 | 99 | 2 | PS50276 | |
| Domain | Hormone_3 | 8.32e-05 | 3 | 99 | 2 | PF00159 | |
| Domain | PANCREATIC_HORMONE_1 | 8.32e-05 | 3 | 99 | 2 | PS00265 | |
| Domain | AAA+_ATPase | 1.18e-04 | 144 | 99 | 6 | IPR003593 | |
| Domain | AAA | 1.18e-04 | 144 | 99 | 6 | SM00382 | |
| Domain | TF_Zn_Ribbon | 1.66e-04 | 4 | 99 | 2 | PF08271 | |
| Domain | Znf_TFIIB | 1.66e-04 | 4 | 99 | 2 | IPR013137 | |
| Domain | Sema | 5.83e-04 | 31 | 99 | 3 | SM00630 | |
| Domain | Semap_dom | 5.83e-04 | 31 | 99 | 3 | IPR001627 | |
| Domain | Sema | 5.83e-04 | 31 | 99 | 3 | PF01403 | |
| Domain | SEMA | 5.83e-04 | 31 | 99 | 3 | PS51004 | |
| Domain | Ig_2 | 6.11e-04 | 73 | 99 | 4 | PF13895 | |
| Domain | PSI | 6.41e-04 | 32 | 99 | 3 | PF01437 | |
| Domain | Plexin_repeat | 6.41e-04 | 32 | 99 | 3 | IPR002165 | |
| Domain | Plexin_cytopl | 9.77e-04 | 9 | 99 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 9.77e-04 | 9 | 99 | 2 | IPR013548 | |
| Domain | Plexin | 9.77e-04 | 9 | 99 | 2 | IPR031148 | |
| Domain | TyrKc | 1.23e-03 | 88 | 99 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.23e-03 | 88 | 99 | 4 | IPR020635 | |
| Domain | PSI | 1.63e-03 | 44 | 99 | 3 | IPR016201 | |
| Domain | PROTEIN_KINASE_TYR | 1.77e-03 | 97 | 99 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.77e-03 | 97 | 99 | 4 | IPR008266 | |
| Domain | PSI | 1.86e-03 | 46 | 99 | 3 | SM00423 | |
| Domain | WW | 1.98e-03 | 47 | 99 | 3 | PF00397 | |
| Domain | OTU | 2.09e-03 | 13 | 99 | 2 | PF02338 | |
| Domain | WW | 2.10e-03 | 48 | 99 | 3 | SM00456 | |
| Domain | WW_DOMAIN_2 | 2.50e-03 | 51 | 99 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 2.50e-03 | 51 | 99 | 3 | PS01159 | |
| Domain | WW_dom | 2.64e-03 | 52 | 99 | 3 | IPR001202 | |
| Domain | Sushi | 2.64e-03 | 52 | 99 | 3 | PF00084 | |
| Domain | - | 2.70e-03 | 663 | 99 | 10 | 2.60.40.10 | |
| Domain | OTU | 2.79e-03 | 15 | 99 | 2 | PS50802 | |
| Domain | OTU_dom | 2.79e-03 | 15 | 99 | 2 | IPR003323 | |
| Domain | CCP | 2.95e-03 | 54 | 99 | 3 | SM00032 | |
| Domain | SUSHI | 3.27e-03 | 56 | 99 | 3 | PS50923 | |
| Domain | ig | 3.42e-03 | 190 | 99 | 5 | PF00047 | |
| Domain | Immunoglobulin | 3.42e-03 | 190 | 99 | 5 | IPR013151 | |
| Domain | Sushi_SCR_CCP_dom | 3.44e-03 | 57 | 99 | 3 | IPR000436 | |
| Domain | Ig-like_fold | 4.22e-03 | 706 | 99 | 10 | IPR013783 | |
| Domain | Pkinase_Tyr | 4.93e-03 | 129 | 99 | 4 | PF07714 | |
| Domain | P-loop_NTPase | DNAH3 AK9 SMARCAD1 UPF1 CLPX MAGI2 TJP1 ASPM ABCD1 DNAH6 DNAH11 | 5.24e-03 | 848 | 99 | 11 | IPR027417 |
| Pubmed | 6.30e-08 | 14 | 100 | 4 | 18454175 | ||
| Pubmed | 6.30e-08 | 14 | 100 | 4 | 9212243 | ||
| Pubmed | 6.30e-08 | 14 | 100 | 4 | 1648219 | ||
| Pubmed | Disruption of Nectin-like 1 cell adhesion molecule leads to delayed axonal myelination in the CNS. | 2.41e-07 | 19 | 100 | 4 | 19036974 | |
| Pubmed | 2.41e-07 | 19 | 100 | 4 | 23827681 | ||
| Pubmed | 1.28e-06 | 8 | 100 | 3 | 1690992 | ||
| Pubmed | 4.90e-06 | 39 | 100 | 4 | 1676977 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 6.46e-06 | 13 | 100 | 3 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 6.46e-06 | 13 | 100 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 6.46e-06 | 13 | 100 | 3 | 16638824 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 20044046 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 32150576 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 6265583 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 6.46e-06 | 13 | 100 | 3 | 12832451 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 6.46e-06 | 13 | 100 | 3 | 21670291 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 22162753 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 2702644 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 8380065 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 1279194 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 25724769 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 6.46e-06 | 13 | 100 | 3 | 22092845 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 11801635 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 6.46e-06 | 13 | 100 | 3 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 6.46e-06 | 13 | 100 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 6.46e-06 | 13 | 100 | 3 | 23800882 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 19285068 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 21760897 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 6.46e-06 | 13 | 100 | 3 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 6.46e-06 | 13 | 100 | 3 | 39168268 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 8402684 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 16619040 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 6.46e-06 | 13 | 100 | 3 | 8209741 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 6.46e-06 | 13 | 100 | 3 | 21949477 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 26219866 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 2133556 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 32521208 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 19406938 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 6.46e-06 | 13 | 100 | 3 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 6.46e-06 | 13 | 100 | 3 | 19358828 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 16680193 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 6.46e-06 | 13 | 100 | 3 | 34058224 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 10964771 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 32169849 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 6.46e-06 | 13 | 100 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 6.46e-06 | 13 | 100 | 3 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 6.46e-06 | 13 | 100 | 3 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 6.46e-06 | 13 | 100 | 3 | 23935487 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 15331748 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 6.46e-06 | 13 | 100 | 3 | 22406619 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 6.46e-06 | 13 | 100 | 3 | 25972571 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 19008452 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 6.46e-06 | 13 | 100 | 3 | 15220458 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 18843289 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 15207636 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 21081647 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 11133662 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 11483763 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 2164599 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 29396368 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 18003729 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 6.46e-06 | 13 | 100 | 3 | 33352461 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 38381498 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 20739537 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 6.46e-06 | 13 | 100 | 3 | 27695943 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 20404914 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 6.46e-06 | 13 | 100 | 3 | 32027621 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 6.46e-06 | 13 | 100 | 3 | 27777319 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 18848945 | ||
| Pubmed | Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases. | 8.18e-06 | 2 | 100 | 2 | 15987940 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 10488139 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22665498 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12220663 | ||
| Pubmed | Murine bubblegum orthologue is a microsomal very long-chain acyl-CoA synthetase. | 8.18e-06 | 2 | 100 | 2 | 14516277 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23341783 | ||
| Pubmed | Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes. | 8.18e-06 | 2 | 100 | 2 | 11279004 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21633703 | ||
| Pubmed | The estrogen-responsive B box protein: a novel regulator of keratinocyte differentiation. | 8.18e-06 | 2 | 100 | 2 | 11919186 | |
| Pubmed | Crystal structures of human neuropeptide Y (NPY) and peptide YY (PYY). | 8.18e-06 | 2 | 100 | 2 | 35180645 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17686996 | ||
| Pubmed | ABL tyrosine kinases: evolution of function, regulation, and specificity. | 8.18e-06 | 2 | 100 | 2 | 20841568 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31342168 | ||
| Pubmed | The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy. | 8.18e-06 | 2 | 100 | 2 | 35437018 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 32251645 | ||
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 7.90e-08 | 11 | 73 | 4 | 1315 | |
| GeneFamily | Dyneins, axonemal | 4.12e-05 | 17 | 73 | 3 | 536 | |
| GeneFamily | OTU domain containing | 4.12e-05 | 17 | 73 | 3 | 669 | |
| GeneFamily | Plexins | 5.68e-04 | 9 | 73 | 2 | 683 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.58e-03 | 57 | 73 | 3 | 1179 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.21e-03 | 21 | 73 | 2 | 813 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.68e-08 | 163 | 100 | 7 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.68e-08 | 163 | 100 | 7 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-07 | 196 | 100 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-07 | 196 | 100 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-06 | 162 | 100 | 6 | bfaeff19bb56598fdc8c82be71d51787cf13928f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-06 | 171 | 100 | 6 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.40e-06 | 181 | 100 | 6 | 9cd5e5c285c2b628db9d59709af053defd7c0aff | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.51e-06 | 182 | 100 | 6 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.85e-06 | 185 | 100 | 6 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.98e-06 | 186 | 100 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.10e-06 | 187 | 100 | 6 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.23e-06 | 188 | 100 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-06 | 190 | 100 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-06 | 190 | 100 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-06 | 191 | 100 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.63e-06 | 191 | 100 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-06 | 192 | 100 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-06 | 192 | 100 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-06 | 192 | 100 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 195 | 100 | 6 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 195 | 100 | 6 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 195 | 100 | 6 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 197 | 100 | 6 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-06 | 197 | 100 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 197 | 100 | 6 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 197 | 100 | 6 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.86e-06 | 199 | 100 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 6.03e-06 | 200 | 100 | 6 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 6.03e-06 | 200 | 100 | 6 | 9769185abae084ffac36420c749625e679b70ca8 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.30e-05 | 134 | 100 | 5 | 2647453f44b0e0a8f27ef9bba750e99eb40efc8b | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 26 | 100 | 3 | e2db677bc0f2011883c8b44058276ecf879d4303 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-05 | 169 | 100 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-05 | 169 | 100 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 170 | 100 | 5 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 170 | 100 | 5 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 172 | 100 | 5 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 172 | 100 | 5 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-05 | 176 | 100 | 5 | 8e4600efeea095a92178cfd26d7c58db7dfc0c80 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.09e-05 | 178 | 100 | 5 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.09e-05 | 178 | 100 | 5 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.23e-05 | 179 | 100 | 5 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-05 | 179 | 100 | 5 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-05 | 181 | 100 | 5 | 0c3f469bed108994ed696230e3c30343f7a301d3 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 5.96e-05 | 184 | 100 | 5 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 6.11e-05 | 185 | 100 | 5 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.11e-05 | 185 | 100 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-05 | 185 | 100 | 5 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-05 | 185 | 100 | 5 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.27e-05 | 186 | 100 | 5 | 41e03be964044dae690d566bd078dab3d8045eba | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 186 | 100 | 5 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 186 | 100 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 186 | 100 | 5 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 186 | 100 | 5 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.43e-05 | 187 | 100 | 5 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.43e-05 | 187 | 100 | 5 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.43e-05 | 187 | 100 | 5 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | Endothelial-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.59e-05 | 188 | 100 | 5 | ecb74d67314a43b5805b7f2a7bb9ff6c5a60200a | |
| ToppCell | PND07-28-samps-Endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.76e-05 | 189 | 100 | 5 | eb2f8c8a90e5e9f6697a2d13274c94f40e1973e4 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 6.76e-05 | 189 | 100 | 5 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.76e-05 | 189 | 100 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.76e-05 | 189 | 100 | 5 | d4a25d59d88325d3b20f4287e9b1160c82961a96 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.93e-05 | 190 | 100 | 5 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.93e-05 | 190 | 100 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 190 | 100 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.93e-05 | 190 | 100 | 5 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.93e-05 | 190 | 100 | 5 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.11e-05 | 191 | 100 | 5 | 44c596984c6196f6014e0e405dbe5560841e54ff | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.11e-05 | 191 | 100 | 5 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | E16.5-samps-Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.11e-05 | 191 | 100 | 5 | e7521d4d24f016d4e531cd492a7a69604f0c9e6f | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 7.11e-05 | 191 | 100 | 5 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 191 | 100 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 191 | 100 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 191 | 100 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 191 | 100 | 5 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 191 | 100 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 191 | 100 | 5 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.28e-05 | 192 | 100 | 5 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.28e-05 | 192 | 100 | 5 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.28e-05 | 192 | 100 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.28e-05 | 192 | 100 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.28e-05 | 192 | 100 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 7.28e-05 | 192 | 100 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.28e-05 | 192 | 100 | 5 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.28e-05 | 192 | 100 | 5 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | E15.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.46e-05 | 193 | 100 | 5 | 9f4ffce4e1440b009b0b5947ebf52b12a644704d | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.46e-05 | 193 | 100 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.46e-05 | 193 | 100 | 5 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.46e-05 | 193 | 100 | 5 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.46e-05 | 193 | 100 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | E15.5-Endothelial-proliferative_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.46e-05 | 193 | 100 | 5 | ed6fc4f731624be702563d7d2f0bf366bec1e042 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.46e-05 | 193 | 100 | 5 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 194 | 100 | 5 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 194 | 100 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.65e-05 | 194 | 100 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 194 | 100 | 5 | 68efc6df31479839a3bd5fe9fbc98ddceecc3b10 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 194 | 100 | 5 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-05 | 194 | 100 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 194 | 100 | 5 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 194 | 100 | 5 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| Disease | cD177 antigen measurement | 2.80e-05 | 18 | 98 | 3 | EFO_0021866 | |
| Disease | wheezing | 6.63e-05 | 65 | 98 | 4 | EFO_0009715 | |
| Disease | adrenoleukodystrophy (implicated_via_orthology) | 2.27e-04 | 7 | 98 | 2 | DOID:10588 (implicated_via_orthology) | |
| Disease | complement factor H-related protein 4 measurement | 5.86e-04 | 49 | 98 | 3 | EFO_0600091 | |
| Disease | visual epilepsy (is_implicated_in) | 5.89e-04 | 11 | 98 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | kynurenic acid measurement | 8.32e-04 | 13 | 98 | 2 | EFO_0010506 | |
| Disease | Down syndrome (implicated_via_orthology) | 1.11e-03 | 15 | 98 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Anorexia | 1.61e-03 | 18 | 98 | 2 | C0003123 | |
| Disease | serum carcinoembryonic antigen measurement | 2.00e-03 | 20 | 98 | 2 | EFO_0005760 | |
| Disease | Epilepsy, Cryptogenic | 2.60e-03 | 82 | 98 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 2.60e-03 | 82 | 98 | 3 | C0751111 | |
| Disease | Aura | 2.60e-03 | 82 | 98 | 3 | C0236018 | |
| Disease | mental or behavioural disorder | 3.04e-03 | 179 | 98 | 4 | EFO_0000677 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QSENGRYHEEYLYRA | 786 | Q9NP73 | |
| SVAVYNHYKRIYNNI | 191 | O76031 | |
| QLSISLRYEGRVYHY | 206 | P42684 | |
| LRYEGRVYHYRINTT | 211 | P42684 | |
| RHSYEYQRENSSYRS | 96 | P49760 | |
| STRYYQNERRHNYTT | 3056 | Q96DT5 | |
| YQHVLLYLQLYDSSR | 1366 | Q5JWR5 | |
| RRYLFRDYVESHYQL | 211 | O95376 | |
| SYYLHTIDRTILENY | 311 | Q8TEK3 | |
| RDRQGYTAVHYAAAY | 546 | Q8NB46 | |
| RNRRSLSGYNYEVYH | 126 | Q8N4T0 | |
| QKYYRAYSIGREQNH | 2001 | Q8IZT6 | |
| ASILIQQHYRTYRAA | 2506 | Q8IZT6 | |
| SFYDQREYIGRSVHY | 591 | P49792 | |
| NRYYASLRHYLNLVT | 46 | P10082 | |
| YRDYSADGQLLHYRT | 186 | Q9C0H5 | |
| YQFFRIYYLNVVTHS | 241 | Q7Z602 | |
| SRLYTYKRTHAAYNL | 256 | Q969V3 | |
| SLHLQLIRNYVEVYY | 301 | Q5T5X7 | |
| LVAHAYRLYFSQQTY | 166 | P33897 | |
| LHYQVYAAERTRFQT | 241 | Q86T65 | |
| SYLEYRHNASIRVYQ | 1511 | P23467 | |
| RHNASIRVYQTNYFA | 1516 | P23467 | |
| IYGTYYVDHINRRTQ | 361 | Q86UL8 | |
| RHNYETYLEYISRTS | 541 | Q86UL8 | |
| QHNRRLYVYYSVGIR | 261 | Q96JK4 | |
| HETTHYYQLSLRSYR | 356 | Q8NE63 | |
| YVVYYVRHNQEDARR | 221 | Q9BY71 | |
| IHELGYNTYASRLYR | 121 | P11487 | |
| SSQAFRYVLHYYRTG | 106 | Q6PIU1 | |
| FSRQYAHIYATRLIQ | 46 | P49005 | |
| QYRIGHYRFRYSDTL | 101 | P24071 | |
| AYVSRVCLRDQHYYS | 246 | O43157 | |
| ALQELYNHIHRYYDQ | 1861 | Q9ULL4 | |
| YNHIHRYYDQIISAL | 1866 | Q9ULL4 | |
| YTYLQSIHNYSEREG | 256 | Q8NGV0 | |
| YNTLHYYEMHLRDRA | 1006 | Q9ULK4 | |
| DTRQRIHDYYEHRYQ | 546 | Q9Y3Q4 | |
| RCHSYNLTVQYQYVF | 416 | O14522 | |
| AYRYGEHYDSVRRIN | 176 | Q5T2D3 | |
| YAVRHTIQVYRLSKY | 296 | Q96BN8 | |
| HVLLRYEDAYQYQNI | 291 | Q92900 | |
| NDYYTISQRAVTHIY | 231 | Q9C0G6 | |
| YYFAVHATVYRASLQ | 151 | Q9BXJ0 | |
| YVISKHRARNYYTDT | 996 | P20023 | |
| VIVHRRYQYLSAAYS | 121 | Q96HP0 | |
| SLDYYNKLRRHNYVT | 2636 | Q8TD57 | |
| LYVRDNTAVHQVYYD | 286 | Q8WW52 | |
| AYRRLIDQYGTHYLQ | 291 | P10643 | |
| RYEGRVYHYRINTAS | 166 | P00519 | |
| EHISYSQYYLLARRA | 131 | Q96GR2 | |
| YYQQAYRHSGIRAAR | 96 | Q9HAW0 | |
| VQSLRVYSDLHAFYY | 96 | Q5VSG8 | |
| AYYEHIHQAVRLYNL | 846 | P49641 | |
| QELSHYRAVLSRYQA | 306 | Q10586 | |
| RTHYQQLLAYEDRLY | 186 | Q8NFL0 | |
| QIRDLYHYITSYVVD | 71 | Q9UQ72 | |
| VSDYVNYDIIVRHYN | 16 | P21453 | |
| AELYYVRNDLISHYA | 81 | P34925 | |
| HQRVYTYIQSRFYRA | 376 | Q92630 | |
| SQQTISDRYYTALYR | 536 | Q03701 | |
| LNRHYYSITINYRKN | 196 | O00487 | |
| HLVQTHYYNYRVSFL | 31 | O75818 | |
| RTLQYYEHQVIGYRD | 111 | P33402 | |
| DSARVRYYQSLQAHL | 216 | Q11128 | |
| TTRHNYYFINYRTLV | 86 | P29083 | |
| GSINYALEYHNRIYI | 1746 | Q5TCS8 | |
| HSNRIYDYNSVIRLY | 556 | Q9Y5X1 | |
| HFARYYSESQERNLL | 566 | Q93075 | |
| HSRYEDYNVIVTTYN | 591 | Q9H4L7 | |
| RYRNGDAYTTTQVYH | 181 | Q8IW70 | |
| LYYHTLANTRAYQQS | 361 | Q96LT4 | |
| RQSFQYRLASLYLHY | 36 | A6NCM1 | |
| QIRDLYHYITSYVVD | 71 | Q9UQ74 | |
| AQFHYLIQVYTGYRR | 741 | Q7Z443 | |
| QIRDLYHYVTSYIVD | 71 | Q13046 | |
| YNYGIRNYRFHTISH | 196 | Q9NZ20 | |
| FLYYTVENSRVYHLE | 566 | Q9H6W3 | |
| STRQYHLQQLFYRYG | 51 | Q13433 | |
| YGLTNDHYSITLRRY | 486 | P25054 | |
| LFHRGYYRNSYNSIT | 6 | P51790 | |
| LSREIYSADYYRVQS | 636 | Q01973 | |
| YAIVERLNFAYYLHN | 1191 | Q96JI7 | |
| RNHYRVYNLCSERAY | 276 | P56180 | |
| YYIHVDKRSNYLHRQ | 356 | Q86Y38 | |
| LTYHNVYSRDPNYLN | 271 | Q05086 | |
| IRLENAFYEHAQTYY | 186 | Q7Z392 | |
| AQTYYYTEIRRVKSH | 196 | Q7Z392 | |
| YYSRQYSVAFCNHVR | 31 | Q9BZQ8 | |
| EHVIRYTAYDRAYNR | 236 | O60687 | |
| QTIHIRENSYSYNKY | 286 | Q14586 | |
| ARYYSALRHYINLIT | 46 | P01303 | |
| VTIYRHQEYYRGRNN | 1071 | Q9H5I5 | |
| YISKYSVFLRHRYQS | 2226 | Q9HCK1 | |
| HYYLRTSETSYLNEA | 136 | Q8N9R8 | |
| YQLSRLLHDYHRDLY | 1056 | O60343 | |
| YTDQFSRNYEHRLRY | 1066 | Q07157 | |
| RQVLSQQSLYLHRYY | 416 | O95361 | |
| QIRDLYHYITSYVVD | 71 | P11465 | |
| YTFEGARYYINHNER | 66 | Q9HAU0 | |
| NTVDYHYSRQYPVFR | 31 | Q8NFY4 | |
| LYPHQVSARYDQRYL | 471 | Q9Y4E6 | |
| INYFDYLATSYRHVV | 191 | Q2WGJ8 | |
| QVLSQQSLYLHRYYF | 201 | Q309B1 | |
| YYALSHQQKSRAFYR | 341 | P57103 | |
| VYIYHLRCYVYQARN | 1136 | Q9NZM1 |